Modeling & Simulation can help quantify the efficacy-safety profile of a new drug candidate and compare it to existing drugs. Moreover it can suggest how to optimize dose regimens by conducting in silico trials.
In silico clinical trials allow to explore new scenarios that haven’t been considered in real clinical trials. They help to assess the efficacy and safety of anti-cancer treatments and optimize scheduling.
Modeling & Simulation can help quantify the dose-exposure-response relationship. They can be used to guide the design of clinical studies, optimizing the scheduling, study duration and number of subjects and cohorts to include in the trial.